Estimated prevalence of unregistered and falsified medicinal products in Malaysia: a nationwide cross-sectional study conducted from March to November 2023
Background The global proliferation of unregistered and falsified medicinal products poses significant public health risks. In Malaysia, previous studies have shown concerning prevalence rates but are often limited to specific populations and targeted product brands, restricting the generalisability...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis Group
2025-12-01
|
| 叢編: | Journal of Pharmaceutical Policy and Practice |
| 主題: | |
| 在線閱讀: | https://www.tandfonline.com/doi/10.1080/20523211.2025.2557879 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|